Tag: generic drugs

4

Jan

Hatch-Waxman Act: How It Shaped Generic Drug Access in the U.S.

Hatch-Waxman Act: How It Shaped Generic Drug Access in the U.S.

The Hatch-Waxman Act created the modern system for generic drug approval in the U.S., balancing innovation incentives with affordable access. It cut drug costs by billions but also opened doors to patent abuse.

VIEW MORE
25

Nov

Generic vs Brand-Name Drugs: Key Differences Explained

Generic vs Brand-Name Drugs: Key Differences Explained

Generic drugs save up to 85% on costs and work just as well as brand-name versions. Learn how the FDA ensures they're safe, why they look different, and when you might notice a difference.

VIEW MORE
17

Nov

Bioequivalence and Patient Safety: Why Generic Drug Testing Matters

Bioequivalence and Patient Safety: Why Generic Drug Testing Matters

Bioequivalence testing ensures generic drugs work just like brand-name ones. Learn how this science protects patient safety, saves billions, and makes affordable medicine possible.

VIEW MORE
12

Nov

Foreign Manufacturing of Generics: How the FDA Oversees Quality and Safety

Foreign Manufacturing of Generics: How the FDA Oversees Quality and Safety

The FDA now conducts unannounced inspections of foreign generic drug factories to close a safety gap. Learn how CGMP standards, new inspection rules, and global supply chains affect the medicines you take every day.

VIEW MORE